BioCentury | Dec 29, 2020
Distillery Therapeutics

Optimized proline-based MENA inhibitors to treat breast cancer

...Nov. 12, 2020doi:10.1073/pnas.2007213117CONTACT: Peter ten Dijke, Leiden University Medical Center, Leiden, the Netherlandsemail: p.ten_dijke@lumc.nlCONTACT: Hans-Günther Schmalz, University of Cologne...
...Köln, Germanyemail: schmalz@uni-koeln.deCONTACT: Ronald Kühne, Leibniz Research Institute for Molecular Pharmacology, Berlin, Germanyemail: kuehne@fmp-berlin.de Claire Quang Leiden University Medical Center University of Cologne Leibniz...
BioCentury | Jan 4, 2018
Distillery Therapeutics

Cancer

...published Dec. 12, 2017 doi:10.1016/j.celrep.2017.11.063 CONTACT: Markus Chmielewski, the University of Cologne, Cologne, Germany email: markus.chmielewski@uk-koeln.de Elizabeth S. Eaton University of Cologne Carcinoembryonic...
BioCentury | Dec 18, 2017
Preclinical News

IL-18 secreting CAR T cells enhance immune killing of tumors

...In a paper published in Cell Reports , researchers at the University of Cologne showed that a chimeric...
...exhaustion as indicated by PD-1 expression than mice treated with unmodified CAR T cells. Elizabeth S. Eaton University of Cologne Torque...
BioCentury | Mar 17, 2017
Emerging Company Profile

B-ing persistent

...at this year's American Association for Cancer Research (AACR) meeting. Aleta is collaborating with the University of Cologne...
...focus: Cancer Clinical status: Preclinical Founded: 2015 by Paul Rennert and Roy Lobb University collaborators: University of Cologne...
...Mass. American Association for Cancer Research (AACR), Philadelphia, Pa. Endocyte Inc. (NASDAQ:ECYT), West Lafayette, Ind. University of Cologne...
BioCentury | Nov 19, 2015
Distillery Techniques

Techniques: Genomic rearrangements near telomerase reverse transcriptase (TERT) as diagnostic markers of aggressive neuroblastomas

Biomarkers TERT telomerase reverse transcriptase (TERT) University of Cologne BC Staff...
BioCentury | Aug 10, 2015
Company News

apceth, University of Cologne deal

...did not respond in time for publication. apceth GmbH & Co. KG , Munich, Germany University of Cologne...
BioCentury | Apr 16, 2015
Distillery Techniques

Techniques: Cell-permeable peptidomimetics targeting of proline-rich segment (PRS) recognizing domains (PRDs)

...al. Proc. Natl. Acad. Sci. USA; published online Apr. 6, 2015 doi:10.1073/pnas.1422054112 CONTACT: Hans-Günther Schmalz, University of Cologne...
BioCentury | Dec 12, 2013
Distillery Techniques

Technology: Computational models

...Genomic Medicine (NGM). Sci. Transl. Med.; published online Oct. 30, 2013; doi:10.1126/scitranslmed.3006802 Contact: Roman Thomas, University of Cologne...
BioCentury | Jun 10, 2013
Product Development

O-ver and above

...assumptions that may not pan out as data mature," he said. Valentin Goede of the University of Cologne...
...Munich, Germany University of California San Diego Moores Cancer Center , La Jolla, Calif. University of Cologne...
BioCentury | Apr 11, 2013
Cover Story

RET, set, go

...Calif. Pfizer Inc. (NYSE:PFE), New York, N.Y. Seoul National University Hospital , Seoul, South Korea University of Cologne...
...the trial is ongoing. Roman Thomas, chair of the Department of Translational Genomics at the University of Cologne...
Items per page:
1 - 10 of 32
BioCentury | Dec 29, 2020
Distillery Therapeutics

Optimized proline-based MENA inhibitors to treat breast cancer

...Nov. 12, 2020doi:10.1073/pnas.2007213117CONTACT: Peter ten Dijke, Leiden University Medical Center, Leiden, the Netherlandsemail: p.ten_dijke@lumc.nlCONTACT: Hans-Günther Schmalz, University of Cologne...
...Köln, Germanyemail: schmalz@uni-koeln.deCONTACT: Ronald Kühne, Leibniz Research Institute for Molecular Pharmacology, Berlin, Germanyemail: kuehne@fmp-berlin.de Claire Quang Leiden University Medical Center University of Cologne Leibniz...
BioCentury | Jan 4, 2018
Distillery Therapeutics

Cancer

...published Dec. 12, 2017 doi:10.1016/j.celrep.2017.11.063 CONTACT: Markus Chmielewski, the University of Cologne, Cologne, Germany email: markus.chmielewski@uk-koeln.de Elizabeth S. Eaton University of Cologne Carcinoembryonic...
BioCentury | Dec 18, 2017
Preclinical News

IL-18 secreting CAR T cells enhance immune killing of tumors

...In a paper published in Cell Reports , researchers at the University of Cologne showed that a chimeric...
...exhaustion as indicated by PD-1 expression than mice treated with unmodified CAR T cells. Elizabeth S. Eaton University of Cologne Torque...
BioCentury | Mar 17, 2017
Emerging Company Profile

B-ing persistent

...at this year's American Association for Cancer Research (AACR) meeting. Aleta is collaborating with the University of Cologne...
...focus: Cancer Clinical status: Preclinical Founded: 2015 by Paul Rennert and Roy Lobb University collaborators: University of Cologne...
...Mass. American Association for Cancer Research (AACR), Philadelphia, Pa. Endocyte Inc. (NASDAQ:ECYT), West Lafayette, Ind. University of Cologne...
BioCentury | Nov 19, 2015
Distillery Techniques

Techniques: Genomic rearrangements near telomerase reverse transcriptase (TERT) as diagnostic markers of aggressive neuroblastomas

Biomarkers TERT telomerase reverse transcriptase (TERT) University of Cologne BC Staff...
BioCentury | Aug 10, 2015
Company News

apceth, University of Cologne deal

...did not respond in time for publication. apceth GmbH & Co. KG , Munich, Germany University of Cologne...
BioCentury | Apr 16, 2015
Distillery Techniques

Techniques: Cell-permeable peptidomimetics targeting of proline-rich segment (PRS) recognizing domains (PRDs)

...al. Proc. Natl. Acad. Sci. USA; published online Apr. 6, 2015 doi:10.1073/pnas.1422054112 CONTACT: Hans-Günther Schmalz, University of Cologne...
BioCentury | Dec 12, 2013
Distillery Techniques

Technology: Computational models

...Genomic Medicine (NGM). Sci. Transl. Med.; published online Oct. 30, 2013; doi:10.1126/scitranslmed.3006802 Contact: Roman Thomas, University of Cologne...
BioCentury | Jun 10, 2013
Product Development

O-ver and above

...assumptions that may not pan out as data mature," he said. Valentin Goede of the University of Cologne...
...Munich, Germany University of California San Diego Moores Cancer Center , La Jolla, Calif. University of Cologne...
BioCentury | Apr 11, 2013
Cover Story

RET, set, go

...Calif. Pfizer Inc. (NYSE:PFE), New York, N.Y. Seoul National University Hospital , Seoul, South Korea University of Cologne...
...the trial is ongoing. Roman Thomas, chair of the Department of Translational Genomics at the University of Cologne...
Items per page:
1 - 10 of 32